Fusion Pharmaceuticals Inc (FUSN) stock is down -62.86% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives FUSN stock a score of 0 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 0. FUSN's rank also includes a long-term technical score of 0. FUSN has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on FUSN!